K Number
K992991
Device Name
ATRIUM MEDICAL CORPORATION ADVANTA PTFE FACIAL IMPLANT
Date Cleared
2000-01-27

(142 days)

Product Code
Regulation Number
878.3300
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Atrium Advanta TM PTFE Facial Implant is intended for use in Facial Plastic and Reconstructive Surgery.
Device Description
Not Found
More Information

None

Not Found

No
The 510(k) summary describes a physical implant and contains no mention of AI, ML, image processing, or data analysis that would suggest the use of such technologies.

Yes
The device is an implant used in reconstructive and plastic surgery, which aims to treat or modify a bodily function or structure.

No
This device is an implant used in reconstructive surgery, not for diagnosing conditions. Its intended use is to replace or augment tissue, which is a therapeutic rather than diagnostic function.

No

The device is described as a "PTFE Facial Implant," which is a physical, hardware-based medical device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "in Facial Plastic and Reconstructive Surgery." This describes a surgical procedure performed on a patient's body, not a test performed on a sample taken from the body (which is the hallmark of an IVD).
  • Device Description (Not Found): While the description is missing, the intended use strongly suggests a physical implant.
  • No Mention of IVD-related terms: There is no mention of testing, samples, diagnosis based on samples, or any other terms typically associated with IVDs.

IVDs are devices used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This device is an implant used directly in a surgical procedure.

N/A

Intended Use / Indications for Use

The Atrium Advanta TM PTFE Facial Implant is intended for use in Facial Plastic and Reconstructive Surgery.

Product codes

FTL

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Facial

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.3300 Surgical mesh.

(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle or bird-like figure with stylized wings.

Public Health Service

JAN 27 2000

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Karen Hall RA/QA Manager Atrium Medical Corporation 5 Wentworth Drive Hudson, New Hampshire 03051

K992991 Re:

Trade Name: Atrium Medical Corporation Advanta™ PTFE Facial Implant Regulatory Class: II Product Code: FTL Dated: December 3, 1999 Received: December 6, 1999

Dear Ms Hall:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

1

Page 2 - Ms. Karen Hall

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Mail R.P. Ogden

James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

INDICATIONS FOR USE STATEMENT

510(k) Number (if known)K992991
Device Name:Atrium Advanta TM PTFE Facial Implant
Indications for Use:The Atrium Advanta TM PTFE Facial Implant is intended for use in Facial Plastic and Reconstructive Surgery.

PLEASE DO NOTY WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Prescription Use

OR

Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________

NRO for JZD

(Division Sign-Off)
Division of General Restorative Devices K99299
510(k) Number

Atrium Medical Corporation

...